News

Sativex is indicated for spasticity in MS patients who have not responded adequately to other treatments. It is administered as oromucosal spray enabling flexible dosage, which is particularly

The company’s net loss was $1.3m, compared to a net loss of $2.41m for the same period in 2009. Antares Pharma has reported operating loss of $1.23m for

OncoSec will pay Inovio an undisclosed purchase price for the assigned assets and cash fees and a royalty on commercial product sales. The electroporation technology being sold and

Most recently, Robinson has worked as the CEO of WorkWell Systems and held senior roles at UnitedHealth Group, Deloitte Consulting and PriceWaterhouseCoopers in his career. LifeVantage board of

AN2728 is a boron-based small-molecule compound which reduces the production pro-inflammatory cytokines that are the precursors of the inflammation associated with psoriasis. The double-blind, randomised, vehicle-controlled Phase 2b

The Phase I open-label, dose-escalation study will dose up to 16 patients and will determine the maximum tolerated dose (MTD) of Imprime PGG in combination with alemtuzumab and

The company has generated net income of $13.32m, compared to a net income of $1.74m for the same period in 2009. Medidata has reported operating income of $9.91m

According to Bayer HealthCare, Gadavist demonstrated improvement of visualization endpoints in paired Gadavist images compared to pre-contrast images resulted in improved assessment of normal and abnormal CNS anatomy

The patent (US 7,902,152), entitled ‘Use of cobratoxin as an analgesic,’ describes a composition of matter for an analgesia and its method of use. The method of use